title: [Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].
authors.forename: A
authors.initials: A
authors.lastname: Molins
authors.forename: J
authors.initials: J
authors.lastname: Alvarez-Sabín
authors.forename: J
authors.initials: J
authors.lastname: Montalbán
authors.forename: J
authors.initials: J
authors.lastname: Molero
authors.forename: J
authors.initials: J
authors.lastname: Alegre
authors.forename: A
authors.initials: A
authors.lastname: Codina
mesh_terms: D000287:Administration, Topical; D000368:Aged; D005260:Female; D005477:Fluprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*
chemical_list: C010958:9-fluoroprednisolone; D005477:Fluprednisolone
vernacular_title: Miopatía hipopotasémica por administración tópica de 9 alfa flúor-prednisolona.